Elucidata Company
Elucidata delivers ML-ready biomedical molecular data that is curated to accelerate drug discovery.
Founded Date:
2015-01-01
Last Funding Type:
Series A
Headquarters:
Cambridge, Massachusetts, United States
Investors Number:
4.0
Technology:
['BioTech & HealthTech']
Employee Number:
51-100
Industry:
Medical BioTech
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-09-27
Funding Status:
Early Stage Venture
Investor Type:
info@elucidata.io
Total Funding:
23580000.0